Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
Clinical trial NCT07682961 · RECRUITING
Trial details
- NCT number
- NCT07682961
- Sponsor
- Gilead Sciences
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-14
- Primary completion
- 2029-03-01
- Enrollment
- 590
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.